Earnings, adjusted for stock option expense, were 21 cents per share. The biopharmaceutical company posted revenue of $54.5 million in the period. For the current quarter ending in December, Puma ...

As the birthplace of basketball, the U.S. remains the global leader in consumption, projected to grow at a 4.3% CAGR through ...